Healthy subjects
Conditions
Interventions
Group that take 25 mg of cumin aldehyde daily
Placebo group
Sponsors
University of Tsukuba
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Persons between the ages of 65 and 89 at the time the consent form is obtained. (2)Those who do not have a history of diabetes, cerebrovascular disease, cardiovascular disease, cancer, or paralysis (3)Those who can in take cumin essential oil (no allergies or rejection) (4)Those who have no allergy or rejection to gelatin. (5)Those who regularly consume curry powder-based foods daily but can adjust their intake to 2-3 times. (6)Those who have not participated or are not currently participating in any other clinical research within the past 3 months. (7)Those who fully understand the content of this study and are able to commute to the study site on their own.
Exclusion criteria
Exclusion criteria: Subjects with dementia (MMSE<-23 points) and depressions (GDS>-11 points). And/or are taking these medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function test | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood concentration of amyloid 1-40 Blood concentration of amyloid 1-42 Brain-derived neurotrophic factor "Trail making peg" test Geriatric Depression Scale Pittsburgh Sleep Quality Index Profile of Mood States 2nd Edition Physical Activity Scale for the Elderly SF8 Health Survey d-ROMs BAP Body composition measured by bioelectrical impedance analysis | — |
Countries
Japan
Contacts
Public ContactTomohiro Okura
University of Tsukuba Faculty of Health and sport science
Outcome results
None listed